Charles Ryan Burkett, MD | |
515 Pacific Ave Ste 2, Audubon, IA 50025-1056 | |
(712) 563-4611 | |
(412) 563-2498 |
Full Name | Charles Ryan Burkett |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 9 Years |
Location | 515 Pacific Ave Ste 2, Audubon, Iowa |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548654189 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 44629 (Iowa) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Methodist Fremont Health | Fremont, NE | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Physicians Clinic Inc | 4880506062 | 497 |
Unmc Physicians | 6002728391 | 1320 |
News Archive
Taking the medication metformin hydrochloride was associated with reduced risk of developing the sight-threatening disease open-angle glaucoma in people with diabetes, according to a study published online by JAMA Ophthalmology.
Accuray Incorporated announced today that the company will highlight new CyberKnife and TomoTherapy technologies at the European Society for Therapeutic Radiology and Oncology meeting, booth #2100, in Barcelona, Spain, April 24 – 27, 2015.
Harborview Medical Center's Medical Coronary Intensive Care Unit has received a gold-level Beacon Award for Excellence from the American Association of Critical-Care Nurses.
The success of a new and experimental stem cell treatment used in animals could lead to a novel heart repair therapy for heart attack patients.
› Verified 9 days ago
Entity Name | Unmc Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417912114 PECOS PAC ID: 6002728391 Enrollment ID: O20031104000664 |
News Archive
Taking the medication metformin hydrochloride was associated with reduced risk of developing the sight-threatening disease open-angle glaucoma in people with diabetes, according to a study published online by JAMA Ophthalmology.
Accuray Incorporated announced today that the company will highlight new CyberKnife and TomoTherapy technologies at the European Society for Therapeutic Radiology and Oncology meeting, booth #2100, in Barcelona, Spain, April 24 – 27, 2015.
Harborview Medical Center's Medical Coronary Intensive Care Unit has received a gold-level Beacon Award for Excellence from the American Association of Critical-Care Nurses.
The success of a new and experimental stem cell treatment used in animals could lead to a novel heart repair therapy for heart attack patients.
› Verified 9 days ago
Entity Name | Physicians Clinic Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1821049156 PECOS PAC ID: 4880506062 Enrollment ID: O20031105000345 |
News Archive
Taking the medication metformin hydrochloride was associated with reduced risk of developing the sight-threatening disease open-angle glaucoma in people with diabetes, according to a study published online by JAMA Ophthalmology.
Accuray Incorporated announced today that the company will highlight new CyberKnife and TomoTherapy technologies at the European Society for Therapeutic Radiology and Oncology meeting, booth #2100, in Barcelona, Spain, April 24 – 27, 2015.
Harborview Medical Center's Medical Coronary Intensive Care Unit has received a gold-level Beacon Award for Excellence from the American Association of Critical-Care Nurses.
The success of a new and experimental stem cell treatment used in animals could lead to a novel heart repair therapy for heart attack patients.
› Verified 9 days ago
Entity Name | Madonna Rehabilitation Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417045642 PECOS PAC ID: 0446164081 Enrollment ID: O20031118000079 |
News Archive
Taking the medication metformin hydrochloride was associated with reduced risk of developing the sight-threatening disease open-angle glaucoma in people with diabetes, according to a study published online by JAMA Ophthalmology.
Accuray Incorporated announced today that the company will highlight new CyberKnife and TomoTherapy technologies at the European Society for Therapeutic Radiology and Oncology meeting, booth #2100, in Barcelona, Spain, April 24 – 27, 2015.
Harborview Medical Center's Medical Coronary Intensive Care Unit has received a gold-level Beacon Award for Excellence from the American Association of Critical-Care Nurses.
The success of a new and experimental stem cell treatment used in animals could lead to a novel heart repair therapy for heart attack patients.
› Verified 9 days ago
Entity Name | Teledigm Physician Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548667256 PECOS PAC ID: 6002130283 Enrollment ID: O20150116000478 |
News Archive
Taking the medication metformin hydrochloride was associated with reduced risk of developing the sight-threatening disease open-angle glaucoma in people with diabetes, according to a study published online by JAMA Ophthalmology.
Accuray Incorporated announced today that the company will highlight new CyberKnife and TomoTherapy technologies at the European Society for Therapeutic Radiology and Oncology meeting, booth #2100, in Barcelona, Spain, April 24 – 27, 2015.
Harborview Medical Center's Medical Coronary Intensive Care Unit has received a gold-level Beacon Award for Excellence from the American Association of Critical-Care Nurses.
The success of a new and experimental stem cell treatment used in animals could lead to a novel heart repair therapy for heart attack patients.
› Verified 9 days ago
Entity Name | Grand Island Regional Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225658495 PECOS PAC ID: 0143659508 Enrollment ID: O20200904000271 |
News Archive
Taking the medication metformin hydrochloride was associated with reduced risk of developing the sight-threatening disease open-angle glaucoma in people with diabetes, according to a study published online by JAMA Ophthalmology.
Accuray Incorporated announced today that the company will highlight new CyberKnife and TomoTherapy technologies at the European Society for Therapeutic Radiology and Oncology meeting, booth #2100, in Barcelona, Spain, April 24 – 27, 2015.
Harborview Medical Center's Medical Coronary Intensive Care Unit has received a gold-level Beacon Award for Excellence from the American Association of Critical-Care Nurses.
The success of a new and experimental stem cell treatment used in animals could lead to a novel heart repair therapy for heart attack patients.
› Verified 9 days ago
Entity Name | Bryan Hospital Kearney |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033875380 PECOS PAC ID: 5991195547 Enrollment ID: O20211214002678 |
News Archive
Taking the medication metformin hydrochloride was associated with reduced risk of developing the sight-threatening disease open-angle glaucoma in people with diabetes, according to a study published online by JAMA Ophthalmology.
Accuray Incorporated announced today that the company will highlight new CyberKnife and TomoTherapy technologies at the European Society for Therapeutic Radiology and Oncology meeting, booth #2100, in Barcelona, Spain, April 24 – 27, 2015.
Harborview Medical Center's Medical Coronary Intensive Care Unit has received a gold-level Beacon Award for Excellence from the American Association of Critical-Care Nurses.
The success of a new and experimental stem cell treatment used in animals could lead to a novel heart repair therapy for heart attack patients.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Charles Ryan Burkett, MD 515 Pacific Ave, Audubon, IA 50025-1056 Ph: (402) 505-2622 | Charles Ryan Burkett, MD 515 Pacific Ave Ste 2, Audubon, IA 50025-1056 Ph: (712) 563-4611 |
News Archive
Taking the medication metformin hydrochloride was associated with reduced risk of developing the sight-threatening disease open-angle glaucoma in people with diabetes, according to a study published online by JAMA Ophthalmology.
Accuray Incorporated announced today that the company will highlight new CyberKnife and TomoTherapy technologies at the European Society for Therapeutic Radiology and Oncology meeting, booth #2100, in Barcelona, Spain, April 24 – 27, 2015.
Harborview Medical Center's Medical Coronary Intensive Care Unit has received a gold-level Beacon Award for Excellence from the American Association of Critical-Care Nurses.
The success of a new and experimental stem cell treatment used in animals could lead to a novel heart repair therapy for heart attack patients.
› Verified 9 days ago
Terry L Sprague, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 222 Broadway, Audubon Medical Clinic, Audubon, IA 50025 Phone: 712-563-4206 Fax: 712-563-2001 | |
James Michael Cunningham, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 515 Pacific Ave Ste 2, Audubon, IA 50025 Phone: 712-563-4611 Fax: 712-563-2498 | |
Dr. Stephanie Vampola-runyan, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 515 Pacific Ave, Audubon, IA 50025 Phone: 712-563-4611 Fax: 563-742-4355 |